Patrick Frost, PhD

Patrick Frost, PhD

Jan 15, 2016

Group 6 Copy 48
2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Sea turtle egg fusariosis: unraveling the biology of an emerging fungal pathogen

Sea turtle egg fusariosis is caused by two fungal pathogens, Fusarium keratoplasticum and Fusarium falciforme...

Where are the Pacific harbor seals in Mexico?

Pacific Harbor seals use land to give birth to pups and molt, but once they return to the ocean to forage many...

Backer Badge Funded